Prothena Corporation plc Dividends
The next dividend date for Prothena Corporation plc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Prothena Corporation plc (PRTA)
More About Prothena Corporation plc
Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States. Its product pipeline include Prasinezumab, an investigational humanized monoclonal antibody which is in phase 2b clinical trial, as well as phase 1 and 2 clinical trials for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in phase 2 clinical trial for potential treatment of transthyretin amyloidosis; BMS-986446, an investigational antibody, which is in phase 2 clinical trial to treat Alzheimer's disease; PRX012, an investigational antibody, which is in phase 1 clinical trial to treat Alzheimer's disease; PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer's disease; and PRX019, an investigational antibody, which is in phase 1 clinical trial for the potential treatment of neurodegenerative diseases. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. Prothena Corporation plc was incorporated in 2012 and is based in Dublin, Ireland.
Owning Prothena Corporation plc Stock on the Dividend Date
If you own Prothena Corporation plc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Prothena Corporation plc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Prothena Corporation plc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Prothena Corporation plc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Prothena Corporation plc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Prothena Corporation plc Dividends
You can contact us any time if you would like to ask questions about Prothena Corporation plc dividends or anything else related to the stock market.